Local and systemic responses to SARS-CoV-2 infection in children and adults

Masahiro Yoshida(Jikei University School of Medicine), Kaylee B. Worlock(University College London), Ni Huang(Wellcome Sanger Institute), Rik G.H. Lindeboom(Wellcome Sanger Institute), Colin R. Butler(Great Ormond Street Hospital), Natsuhiko Kumasaka(Wellcome Sanger Institute), Cecilia Domínguez Conde(Wellcome Sanger Institute), Lira Mamanova(Wellcome Sanger Institute), Liam Bolt(Wellcome Sanger Institute), Laura Richardson(Wellcome Sanger Institute), Krzysztof Polański(Wellcome Sanger Institute), Elo Madissoon(European Bioinformatics Institute), Josephine L. Barnes(University College London), Jessica Allen-Hyttinen(University College London), Eliz Kilich(University College London Hospitals NHS Foundation Trust), Brendan C. Jones(Great Ormond Street Hospital), Angus de Wilton(University College London Hospitals NHS Foundation Trust), Anna Wilbrey-Clark(Wellcome Sanger Institute), Waradon Sungnak(Wellcome Sanger Institute), J. Patrick Pett(Wellcome Sanger Institute), Juliane Weller(Wellcome Sanger Institute), Elena Prigmore(Wellcome Sanger Institute), Henry Yung(University College London Hospitals NHS Foundation Trust), Puja Mehta(University College London Hospitals NHS Foundation Trust), Aarash Saleh(Royal Free London NHS Foundation Trust), Anita Saigal(Royal Free London NHS Foundation Trust), Vivian Chu(Royal Free London NHS Foundation Trust), Jonathan Cohen(University College London Hospitals NHS Foundation Trust), Clare Cane(Royal Free London NHS Foundation Trust), Aikaterini Iordanidou(Royal Free London NHS Foundation Trust), Soichi Shibuya(Great Ormond Street Hospital), Ann‐Kathrin Reuschl(University College London), Iván T. Herczeg(University College London), A. Christine Argento(Northwestern University), Richard G. Wunderink(Northwestern University), Sean B. Smith(Northwestern University), Taylor A. Poor(Northwestern University), Catherine A. Gao(Northwestern University), Jane E. Dematte(Northwestern University), NU SCRIPT Study Investigators(University College London), G. R. Scott Budinger(Northwestern University), Helen K. Donnelly(Northwestern University), Nikolay S. Markov(Northwestern University), Ziyan Lu(Northwestern University), Gary Reynolds(Newcastle University), Muzlifah Haniffa(University of Cambridge), Georgina Bowyer(University of Cambridge), Matthew Coates(University of Cambridge), Menna R. Clatworthy(Wellcome/MRC Cambridge Stem Cell Institute), Fernando J. Calero‐Nieto(Wellcome/MRC Cambridge Stem Cell Institute), Berthold Göttgens(Wellcome/MRC Cambridge Stem Cell Institute), Christopher O’Callaghan(Great Ormond Street Hospital for Children NHS Foundation Trust), Neil J. Sebire(Great Ormond Street Hospital), Clare Jolly(Great Ormond Street Hospital for Children NHS Foundation Trust), Paolo De Coppi(Great Ormond Street Hospital), Claire M. Smith(Northwestern University), Alexander V. Misharin(Northwestern University), Sam M. Janes(University College London Hospitals NHS Foundation Trust), Sarah A. Teichmann(University College London Hospitals NHS Foundation Trust), Marko Nikolić(University College London Hospitals NHS Foundation Trust), Kerstin B. Meyer(Wellcome Sanger Institute)
Nature
December 22, 2021
Cited by 356Open Access
Full Text

Abstract

. Here, to examine the differences between children and adults in their response to SARS-CoV-2 infection, we analysed paediatric and adult patients with COVID-19 as well as healthy control individuals (total n = 93) using single-cell multi-omic profiling of matched nasal, tracheal, bronchial and blood samples. In the airways of healthy paediatric individuals, we observed cells that were already in an interferon-activated state, which after SARS-CoV-2 infection was further induced especially in airway immune cells. We postulate that higher paediatric innate interferon responses restrict viral replication and disease progression. The systemic response in children was characterized by increases in naive lymphocytes and a depletion of natural killer cells, whereas, in adults, cytotoxic T cells and interferon-stimulated subpopulations were significantly increased. We provide evidence that dendritic cells initiate interferon signalling in early infection, and identify epithelial cell states associated with COVID-19 and age. Our matching nasal and blood data show a strong interferon response in the airways with the induction of systemic interferon-stimulated populations, which were substantially reduced in paediatric patients. Together, we provide several mechanisms that explain the milder clinical syndrome observed in children.


Related Papers

No related papers found

Powered by citation graph analysis